Simple Question:
If we show the same cognitive improvements ( or possibly better with different dosages in later trials) for the AD results, would there be the same negative reaction?? In my opinion: no.
AD was always the bigger market and the main focus.
I look forward to the AD results to hopefully put an end all of this conjecture.
Good luck to all holders
This is not financial advice.DYOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.419K | 1.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 63876237 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4097409 | 8 |
View Market Depth
| Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |